Available until 15 June
Join HKDS Champion at the current annual rate
Become a Champion member for $149/year until 15 June and get access to the HKDS directories, 3-pillar scorecards, weekly reviews, and member newsletters. After 15 June, the annual membership returns to its regular price.
Sino Biopharm HKG:1177 – Hong Kong Blue Chip stock
Sino Biopharm (HKG:1177)
Hong Kong Blue Chip Stock • Sector: Medicine
Last updated: 21-May
Next ex-dividend date: 24-Jun
Next ex-dividend date: 24-Jun
Stock Value Score
This score indicates whether the stock currently appears undervalued, fairly priced, or expensive,
based on key valuation metrics such as earnings, book value, and cash flow.
| P/E ratio | 35.00 |
| P/B ratio | 2.66 |
| EPS | 0.15 |
| Beta | 0.84 |
Beta above 1 suggests higher volatility. Below 1 suggests more stability relative to the market.
So what’s the takeaway?
Based on current valuation metrics, the stock appears .
Future changes in earnings, cash flow, or price could materially shift this assessment.
Based on current valuation metrics, the stock appears .
Future changes in earnings, cash flow, or price could materially shift this assessment.
Champion Members see the full 3-Pillar scorecard:
Dividend Growth,
Dividend Safety,
Stock Value.
You need to be logged in to view the rest of the content. Please Log In.
